Baxter International Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/13/2026)
| Balance Sheet | Total Assets | 20,055,000,000.00 | ROE | 30.56 % |
| Balance Sheet | Total Equity | 6,102,000,000.00 | ROA | -4.77 % |
| Cashflow | Capital Expenditures | -513,000,000.00 | P/FCF | 38.32 |
| Cashflow | Free Cash Flow | 332,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 845,000,000.00 | P/CF | 15.06 |
| Income | Earnings per Share (diluted) | -1.87 | Div. Yield | 2.10 % |
| Income | Net Income | -957,000,000.00 | P/E | -13.26 |
| Income | Shares Outstanding | 513,000,000.00 | P/B | 2.08 |
| Income | Total Revenue | 11,244,000,000.00 | P/S | 1.13 |
Ratios calculated on: 10/14/2026
Company Description
Baxter International Inc. (Baxter,) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operated in two segments: BioScience and Medication Delivery. It is engaged in the medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and by patients at home under physician supervision. Baxter manufactures products in 27 countries and sells the products in more than 100 countries. In September 2013, Baxter International Inc completed the acquisition of Gambro AB.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.baxter.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more